Company: SUPN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0001356576-25-000017
Chunk: 544

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1A
Chunk 544
---
 and was reported under cash flows from operating activities. The amount paid was for the milestone that was due upon the FDA acceptance of the SPN-830 NDA for review, which was achieved in the first quarter of 2022.The Company recorded the following changes in fair value of the contingent consideration liabilities for the Adamas CVRs: •For the year ended December 31, 2024, the Company recorded a $7.1 million gain which was primarily driven by the non achievement of Milestone 2024.•For the year ended December 31, 2023, the Company recorded a $1.6 million gain primarily driven by the passage of time.•For the year ended December 31, 2022, the Company recorded $1.6 million gain which was primarily due to changes in market data and revenue projections.

7. Goodwill and Intangible Assets, Net

GoodwillThe following table sets forth the gross carrying amounts of goodwill (dollars in thousands):

114

Table of ContentsSupernus Pharmaceuticals, Inc.Notes to Consolidated Financial Statements (Continued)7. Goodwill and Intangible Assets, Net (Continued)

December 31,2024December 31,2023Goodwill$117,019 $117,019 There were no goodwill impairment charges recognized in 2024 or 2023.Intangible Assets, NetThe following table sets forth the gross carrying amounts and related accumulated amortization of intangibles assets (dollars in thousands):December 31, 2024December 31, 2023Remaining WeightedAverage Life (Years)Carrying Amount, GrossAccumulated AmortizationCarrying Amount, NetCarrying Amount, GrossAccumulated AmortizationCarrying Amount, NetAcquired in-process research and development$124,000 $— $124,000 $124,000 $— $124,000 Intangible assets subject to amortization:Acquired developed technology and product rights5.92661,311 (263,399)397,912 661,311 (190,395)470,916 Capitalized patent defense costs0.0043,820 (43,820)— 43,820 (38,847)4,973 Total intangible assets5.92$829,131 $(307,219)$521,912 $829,131 $(229,242)$599,889 Amortization expense for intangible assets was